BCV
AMRX icon

Banque Cantonale Vaudoise’s Amneal Pharmaceuticals AMRX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,000
Closed -$41K – 1143
2020
Q4 		$41K Hold
9,000
– – ﹤0.01% 960
2020
Q3 		$35K Buy
+9,000
New +$38.5K ﹤0.01% 933

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Banque Cantonale Vaudoise's AMRX Position: Q1 2021 in Review

Banque Cantonale Vaudoise sold out of Amneal Pharmaceuticals (AMRX) in Q1 2021, closing a stake of 9,000 shares — an estimated $41K sold.

Banque Cantonale Vaudoise first reported a position in AMRX in Q3 2020 and held it in 2 quarters. The position peaked at $41K in Q4 2020. 161 funds tracked by Wall St. Rank hold AMRX as of Q1 2021.

  • Banque Cantonale Vaudoise reported no remaining Amneal Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 9,000 Amneal Pharmaceuticals shares in Q1 2021, an estimated $41K.
  • Banque Cantonale Vaudoise first reported a position in Amneal Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Banque Cantonale Vaudoise's Amneal Pharmaceuticals position peaked at $41K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2021, filed 11 May 2021.